View in EDS

Optimal pharmacotherapy to combat the atherogenic lipid triad.

Saved in:
Bibliographic Details
Title: Optimal pharmacotherapy to combat the atherogenic lipid triad.
Authors: Chapman MJ; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research, Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr, Redfern JS, McGovern ME, Giral P
Source: Current opinion in cardiology [Curr Opin Cardiol] 2011 Sep; Vol. 26 (5), pp. 403-11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Lippincott Williams and Wilkins Country of Publication: United States NLM ID: 8608087 Publication Model: Print Cited Medium: Internet ISSN: 1531-7080 (Electronic) Linking ISSN: 02684705 NLM ISO Abbreviation: Curr Opin Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 21730827
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimal pharmacotherapy to combat the atherogenic lipid triad.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chapman+MJ%22">Chapman MJ</searchLink>; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research, Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr<br /><searchLink fieldCode="AU" term="%22Redfern+JS%22">Redfern JS</searchLink><br /><searchLink fieldCode="AU" term="%22McGovern+ME%22">McGovern ME</searchLink><br /><searchLink fieldCode="AU" term="%22Giral+P%22">Giral P</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228608087%22">Current opinion in cardiology</searchLink> [Curr Opin Cardiol] 2011 Sep; Vol. 26 (5), pp. 403-11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+and+Wilkins%22">Lippincott Williams and Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8608087 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1531-7080 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202684705%22">02684705 </searchLink><i>NLM ISO Abbreviation: </i>Curr Opin Cardiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21730827
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/HCO.0b013e32834965e9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 403
    Titles:
      – TitleFull: Optimal pharmacotherapy to combat the atherogenic lipid triad.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chapman MJ
      – PersonEntity:
          Name:
            NameFull: Redfern JS
      – PersonEntity:
          Name:
            NameFull: McGovern ME
      – PersonEntity:
          Name:
            NameFull: Giral P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2011 Sep
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-electronic
              Value: 1531-7080
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Current opinion in cardiology
              Type: main
ResultId 1